SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Angel Medina who wrote (2604)7/15/1998 11:24:00 PM
From: Brian Moloney  Read Replies (1) | Respond to of 3725
 
I'm still here. I haven't had anything worthwhile to say. I usually comment on medical questions and issues. I have no idea about the integrity/sliminess of Imatron's leadership, whether GE is going to be a help or is picking low-hanging fruit, and how much profit has to be made before the stock makes a permanent move. If they really do sell all of those units, then all of the cynics will have to apologize to Lew. The technology is great; it is saving lives daily. We'll just have to be patient. Brian



To: Angel Medina who wrote (2604)7/18/1998 11:38:00 PM
From: Lee Kennedy  Read Replies (2) | Respond to of 3725
 
Hi Angel,

I'm still here.

I found Maxine's report of the meeting encouraging.
Does anyone know how many machines would have to be sold during a quarter to show a profit? I know it's more than it used to be since the Siemens' money is gone, so six might not be enough. However, 26 for the year means we would definitely turn profitable during the latter half of the year. And I find that to be very good news.

Lee


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News